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Introduction 
When the editors of Free Neuropathology, 
Werner and Tibor, approached me about writing an 
autobiography for the journal, similar in scope to 
Sam Ludwin’s excellent piece two years ago [1], I 
confess that I had reservations about writing an 
autobiography, because I never wanted to talk 
about myself. However, after a lengthy hesitation 
and eager discussions with my wife and my former 
scholar and friend, Hans Lassmann, I realized with a 
certain degree of doubt that, on the threshold of 
age 90 years, I could perhaps provide some 
thoughts about the bridges between clinical neu-
rology and neuropathology for those who might be 
interested in the experiences of an old neuroscien-
tist.  
Thus, in lieu of concentrating on my career as 
neuropathologist, I wish to instead write about my 
life in the context of unifying these intrinsically 
linked but disparate areas within the rapidly pro-
gressing scientific world: neurology and neuropa-
thology. This long, and not always easy, path 
through the wide field of practical and theoretical 
neuroscience, as well as other interests, was influ-
enced by my late mother, my beloved wife Elisa-
beth, colleagues, patients, friends, and students 
whom I met during my professional and private life.  
This essay is intended to encourage young col-
leagues to not concentrate exclusively on experi-
mental neuropathology without also considering 
the practical part of the neurosciences since there 
is an urgent need to inspire young neurologists to 
pursue a double career as both a clinician and neu-
roscientist in order to promote progress in the neu-
rosciences. 
Why the appeal of clinical neurology 
and neuropathology? 
There are three principal reasons to try to uni-
fy these two closely connected fields of neurosci-
ence. First and foremost is the aim to help patients 
suffering from disorders of the nervous system by 
trying to make an early diagnosis, provide effective 
treatment, and promote preventive measures. 
Second, is the ongoing need to apply ever-evolving 
basic scientific approaches to diseases of the nerv-
ous system in order to support the clinical neurolo-
Reflections 
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gist in elucidating the pathogenesis of disorders 
afflicting their patients. Neuropathology should be 
pursued not just for its own sake but to aid the 
clinician with the mutual goal to improve diagnoses 
and enable successful therapeutic strategies for 
many hitherto incurable disorders. Lastly, there is 
inherent fascination and fulfillment in using our 
knowledge to elucidate the structure and function 
of the nervous system in the healthy and diseased 
human individual.  
Based on this knowledge, the neuropa-
thologist is able to elucidate much of the back-
ground of disorders of the nervous system using 
immunohistochemical, molecular, biological, and 
ultrastructural methods not only in autopsy mate-
rial but also tissues from living patients, including 
biopsies, cerebrospinal fluid, and blood. Often, 
these images are comparable to modern art (Fig. 
1). The selective and interdisciplinary application of 
these methods may enable the neuropathologist to 
not only make a reasonable diagnosis of many, 
though not all, disorders of the nervous system but 
may also provide insight into the complex pathoge-
netic cascades that are responsible for the onset 
and progression of such disorders. In this respect, 
the neuropathologist is privileged to act as both a 
physician and a basic scientist. 
This retrospective will consider highlights and 
drawbacks in my 63 years of life between clinical 
neurology, neuropathology, and private activities. 
Given my many years of work and limited space 
herein, may my friends, scholars, colleagues, and 
co-workers excuse that I regrettably could not con-
sider all of them in this review.  
Early life and schooling 
I was born May 28, 1931 in Vienna, as the only 
child to Rosa and Alois Jellinger, both with roots 
from Upper Austria and Moravia (near Olomouc). 
My father was an official in the government of 
Lower Austria; my mother, a trained dressmaker, 
was a housewife. In the prewar years, I had a won-
derful and well-kept childhood filled with summer 
vacations in the beautiful surroundings of Vienna 
and in the idyllic countryside, while in the city there 
were increasing tensions, poverty, and changes in 
the political atmosphere. I remember Kurt 
Schuschnigg's radio speech of March 11, 1938, with 
his concluding sentence “May God protect Austria,” 
after which my father commented, “This will be the 
beginning of the end.”  
After Austria's “Anschluss” to the German 
Reich, I attended a public primary school in Vienna 
and later, during World War II, a public secondary 
school (Realgymnasium, also in Vienna), where I 
received basic education in languages, natural sci-
ences, geography, and history. In 1943, to escape 
from air raids on the city, many children were sent 
to live with farmers in the Batschka, then southern 
Hungary, now Serbia. Once there, we had a won-
derful and peaceful time, though the atrocity of 
witnessing the pogroms of Jewish people was never 
far from sight or mind.  
On our way home we passed the then peace-
ful city of Budapest, which I would see again during 
the Hungarian revolution in 1956. Once returned to 
Vienna, in 1944, we had to change school buildings 
due to bombing damages. Air raids were still so 
frequent that I often did not make it home in the 
evenings but had to instead seek shelter along the 
way.  
In September of 1944, we lost our home due 
to an air raid and had to wait for a new flat. Around 
this time, I attended one of the last performances 
of Schiller's Wallenstein trilogy of plays featuring 
the famous actor Werner Krauss in the Vienna 
Burgtheater. Soon afterwards, all theaters were 
closed. On April 13, 1945, during the battle be-
tween German and Russian armies in the city of 
Vienna, I had my first medical “experience” by 
cleaning up brain tissue of Russian soldiers who 
were killed by the projectile from a German tank. 
After my father died in a Russian POW camp in 
1947, my mother and I were left alone to overcome 
the difficult times after the end of the war. She 
worked in her former profession as a dressmaker 
and I became tutor of children.  
In 1949, I graduated high school summa cum 
laude. In that final year, our class contained 18 
boys and, when we had our final exams, I got excel-
lent marks (Fig. 2). After graduation, our class, led 
by our Latin teacher, traveled to Rome and Naples, 
where we enjoyed arts, cuisine, and life in Italy. To 
this day, I remain grateful to my many teachers 
who encouraged me to liberally approach history 
and natural sciences. Years later, one of my favorite 
high school teachers became a patient in my clinic 
with myasthenia gravis, which we treated with 
success. Over the years, my classmates and I met 
several times at reunions to remember and discuss 
previous experiences. The last meeting was 2009 to 
celebrate the 50th anniversary of our graduation. 
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Fig. 1. (A) MS-like autoimmune encephalitis after repeated subcutaneous injections of lyophilized calf brain cells in male aged 51 years 
with hemi-Parkinson syndrome. Left hemisphere with prominent periventrivular demyelinated lesion and multiple demyelinated 
plaques in cortex and subcortical nuclei. From [2] (B) EM image of focal (core) plaque in hippocampus showing dense accumulation of 
thick amyloid fiber bundles, surrounded by dystrophic neuritic endings and hyperintense structure of myelinated axon. (x 4000). Photo: 
K.A. Jellinger. (C) Major histopathological changes in Alzheimer’s disease. (C1) Amyloid deposits in the neuropil (plaques) and vascula-
ture (CAA) (congo red stain). (C2) Neuritic plaque with dystrophic neurites (Bodian stain). (C3) Neurofibrillary tangles (large arrows) and 
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Medical school and beyond 
In 1949, I entered the Medical Faculty of the 
University of Vienna, where the circumstances of 
medical education were made far more difficult 
due to the sequelae of the war. For example, we 
worked in the anatomy theater in winter with 
glassless windows and without warm water. De-
spite this, and with eight of us were working on a 
corpse, we succeeded thanks to the influence of 
our professor, Alfred Gisel, a wonderful teacher 
and enthusiastic anatomist, who, in addition, was 
medical chief of the Austrian Red Cross.  
The curriculum had basic subjects like anato-
my, chemistry, physics, and physiology for 2 years, 
followed by 3 years of theoretical and practical 
training, beginning with pathological anatomy, 
physiology, pharmacology, and clinical specialties. 
Most of our teachers were outstanding, some of 
them scientists of high reputation, such as: Prof. H. 
Tuppy, chemistry (Nobel Price candidate); Prof. F.T. 
Brücke, pharmacology; Prof. G. Schubert, physiolo-
gy; and Prof. H. Chiari, head of pathological anato-
my. During my studies, and despite regular grants, I 
supported myself with work as a paramedic for 
physically disabled people, as a tutor for children 
and students, and as a writer of short stories for 
newspapers and magazines.  
Our clinical teachers were very dedicated and 
regularly organized seminars and clinical practi-
cums, but the majority of teaching was much less 
practical but more formal and didactic than in the 
new curricula. In December 1955, I finished my 
medical studies, but had to wait for my graduation 
due to administrative delay since mine was the first 
“Promotio sub auspiciis Praesidentis rei publicae,” 
the highest possible distinction for academic 
achievements in Austria, in medicine since the end 
of World War II. In the meantime, I worked as guest 
doctor without salary in the Franz Josef Hospital in 
Vienna, within the department of Internal Medicine 
and Surgery, directed by Prof. Herbert Kraus, later 
chairman of the first Department of Neurosurgery 
of Vienna Medical School. On April 14, 1956, I was 
promoted to Doctor of Medicine “sub auspiciis 
praesidentis rei publicae,” which I received in the 
uniform of an officer of the Austrian Red Cross (Fig. 
3).  
Hospital years and first experiences 
In 1956, once the Soviet army left Budapest 
subsequent to the bloody uprising of the Hungarian 
people, I went with a Red Cross convoy to deliver 
medical supplies and blood bottles to the liberated 
citizens of Budapest. We were lucky to return to 
Vienna before the Russian army reconquered Bu-
dapest. 
I enjoyed clinical medicine but my major in-
terest was neuropathology. On January 5, 1957, I 
began as a postdoctoral fellow (wissenschaftliche 
Hilfskraft) at the Neurological Institute (NI) a.k.a. 
Obersteiner Institute of the Vienna Medical School 
headed by Hans Hoff, who was also chairman of 
the neuropsychiatric clinic. Founded by Heinrich 
Obersteiner in 1882 as a box that was subsequently 
expanded by Obersteiner's personal expenses, the 
NI became the first interdisciplinary institute of 
neurosciences and was visited by many scientists 
from Japan, the USA, and other countries. 
 
 
Fig. 2. Our graduation class 1949 together with H.R. Klieba, principal of the Realgymnasium Wien VIII, and Dr. Seifert, our class teacher. 
KJ second left in the first row. 
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Fig. 3. Promotion to Doctor of Medicine 1956 in the uniform of 
a Red Cross officer, with Dr. Heinrich Drimmel, Federal Minis-
ter of Education and Science. 
 
Obersteiner edited a series of publications under 
the title “Arbeiten aus dem Obersteinerschen Insti-
tut” and books about basic neuroanatomy and 
pathology. Together with the Edinger Institute in 
Frankfurt, the NI became one of the leading centers 
of neurosciences in the world until the beginning of 
World War II, when it was directed by Oskar Gagel, 
an experienced neurooncologist. The NI, together 
with the Institute of Histology, occupied the first 
floor in a building of preclinical institutes, next to 
the general hospital of the Vienna Medical School 
(Allgemeines Krankenhaus/AKH). Parts of this area 
had been bomb-damaged during the war. 
My first venture into neuropathology was to 
save and reorganize the large collection of slides 
that included material from major brain diseases. It 
was through this work that I learned the basics of 
neuroanatomy and neuropathology. The NI had a 
huge library, originally compiled by Obersteiner 
himself, which was a treasure trove of rare and 
antique books, including an original edition of 
Thomas Willis' “Circulus arteriosus cerebri,” one of 
the first descriptions of brain vasculature. In 1958, 
Prof. Franz Seitelberger became director of the NI 
(Fig. 4). In the same year, I met and immediately 
fell in love with Elisabeth, a beautiful and clever girl 
aged 21 years, born in Brno (then CSSR), who stud-
ied English, Russian, and history of arts. We attend-
ed theaters, operas, concerts, and frequently met 
in the university library. Elisabeth and I married on 
August 17, 1960. 
Training progress 
During the following years, I was trained by 
Franz Seitelberger, an internationally renowned 
neuropathologist with particular interest in meta-
bolic and neurodegenerative diseases of the nerv-
ous system, who later became dean and rector of 
the University of Vienna. I was in charge of brain 
autopsies (600 to 1000 per year) and diagnostic 
workup of neurosurgical biopsies. 
My early scientific work concerned acute de-
myelinating encephalitis following injections of 
lyophilized calf brain cells in a patient suffering 
from Parkinson's disease (PD) [2] (Fig. 1a). This 
particular case, which closely resembled those of 
patients who received rabies vaccinations in Japan, 
was later re-published as acute autoimmune de-
myelinating encephalitis [4]. Other projects includ-
ed studying the neuropathological side effects of 
the 1958 influenza epidemic and the neuropathol-
ogy of Spring-Summer (tick-borne) encephalitis in 
Austria, which we described in detail.  
In parallel to my work at the NI, I underwent 
specialization in neurology and psychiatry as a 
guest doctor at the University Clinic of Neurology 
and Psychiatry in Vienna, headed by Hans Hoff, 
between January 1958 and December 1963. Among 
my tutors were Klara Weingarten, an excellent clin-
ical neurologist, and Franz Gerstenbrand, later 
chairman of the Clinic of Neurology, Medical Uni-
versity Innsbruck. We examined patients, both 
clinically and neuropathologically, with chronic 
coma or apallic syndrome (now unresponsive 
wakefulness syndrome) following head injury and 
those who suffered hypoxic brain damage and 
found a close relationship between the pattern of 
brainstem lesions due to intracranial pressure, the 
state of consciousness, and clinical outcome.  
In addition to hospital work, I was assistant to 
Prof. Hoff's lectures in neurology, which was often 
difficult since he wanted the patients' histories and 
clinical statuses to be in exact accordance with his 
neurology book. I also heard lectures by Prof. Her-
bert Reisner, an excellent neurologist and psychia-
trist, who later became chairman of the Clinic of 
Neurology of the University of Vienna. After train-
ing in neurology, I worked in the Division of Psychi-
atry, where I got experience in all kinds of psychiat-
ric disorders. On free weekends, I worked as a vol-
untary health officer with the Red Cross. 
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On January 1st, 1960, I was promoted from 
assistant to consultant (Oberarzt) at the NI. I stud-
ied encephalitis and myelitis following poliomyelitis 
vaccination and movement disorders (progressive 
pallidum atrophy and striatonigral degeneration) 
with Erwin Neumeyer, who unfortunately died 
early. In 1961, Elisabeth and I attended the Interna-
tional Congress of Neuropathology in Munich 
where we met all the top scientists in this field. In 
1962, after a lecture on chronic vascular myelopa-
thy at the 25th Reunion Neurologique in Paris, I 
became Membre associé à titre ètranger (associate 
foreign member) of the French Neurology Associa-
tion. During that time, many excellent neuroscien-
tists visited the NI and lectured there, such as Hugo 
Spatz, Hans Jacob, Wilhelm Krücke, chief of the 
Max Planck Institute of Brain Research in Frankfurt, 
Webb Haymaker, chief of the Armed Forces Insti-
tute of Pathology (AFIP), and Ludo van Bogaert of 
Bunge Institute in Antwerp, Belgium, for whom I 
had the honor of translating his lectures. A number 
of postdocs and research fellows, particularly from 
Japan, were trained in the NI, such as Mansori 
Tomonaga, Professor at Tokyo University (his 
charming wife was a wonderful soprano singer), 
Riki Okeda (who counted cells in the pons during 
the the night while listening to classical music), and 
many others (see [5]). It was an exciting time in the 
international neuroscience community!  
Between February and August 1963, I worked 
part-time as guest at the Institute of Pathology, 
Vienna Medical University, chaired by Hans Chiari, 
where I performed general autopsies and brain 
cutting. I detected the first case of clinically-
suspected Creutzfeldt-Jakob disease (CJD), which I 
“stole” in order to study it histologically, with the 
consequence that I was dismissed from the 
morgue. This was the end of my training in general 
pathology, but the relations with this department 
remained excellent. Between 1963 and 1974, I ad-
ditionally worked two afternoons each week as 
chief of the outpatient service of the Anton Proksch 
Institute, a therapy facility for alcoholism and ad-
diction, in order to supplement my low salary as a 
university assistant. With Wichard Kryspin-Exner, 
later chairman of the Department of Psychiatry, 
Medical University of Innsbruck, a number of pa-
pers about the course and prevention of alcoholism 
were published. 
Full-time neuropathology 
In the following years, in addition to routine 
postmortem neuropathology and diagnostic biopsy 
work, I examined vascular spinal cord pathology 
and commented on Zülch's vascular “borderline 
zones.” Other subjects included spinal cord injuries, 
in particular, cervical hyperextension trauma with 
vascular complications. In January 1963, I earned 
board certification as specialist (Facharzt) in neu-
rology and psychiatry and returned as a full-time 
consultant to the NI.  
 
 
Fig. 4. Briefing with Prof. F. Seitelberger (left) and Dr. H. Hoff (right) in the Neurological Institute, 1958. 
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In 1965, a postmortem study of a series of an-
oxic-vascular brain lesions resulting from complica-
tions of open heart surgery caused quite an outcry 
in the surgical community, but, as a consequence, 
the incidence of complications was reduced due to 
changed modalities and techniques in cardiac and 
vascular surgery. At the International Congress of 
Neuropathology in Zurich, I gave a lecture on the 
neuropathology of coma and postcomatose en-
cephalopathies. Then, I began experimental studies 
of spinal cord vasculature in cats and other animals, 
working together with the neurosurgeon Heinrich 
Brenner in the experimental laboratory of the de-
partment of surgery. These studies, together with 
large human postmortem material, were the basis 
for my PhD thesis “Zur Onkologie und Pathologie 
der Rückenmarksdurchblutung” (“On the oncology 
and pathology of spinal cord blood circulation”), 
published in 1966 by Springer Verlag Wien. On Jan-
uary 19, 1966, I was granted the Venia Legendi 
(Dozentur, lecturer) in neurology, neuroanatomy, 
and neuropathology, and became chief of the Divi-
sion of Neuropathology of the NI Vienna. In addi-
tion to routine diagnostic work, I lectured about 
general and specific neuropathology, and per-
formed regular brain cutting sessions for students 
and colleagues who were interested in neuropa-
thology (Fig. 5). In the same year I received the 
Kardinal Innitzer Award for Promotion of Medical 
Research. 
Atypical encephalitides and spinal cord circu-
lation disorders were presented at the 1st meeting 
of the CSSR Neuropathology meeting in Prague in 
September 1966, where Prof. Bednar, chairman of 
die Institute of Pathology of Prague Medical School, 
was a charming host. 1967, with W. Sturm, a series 
of radiation injuries of the cervical spinal cord with 
relation to the applied radiation doses was pub-
lished. At that time of progressing international 
congresses, publications and oral presentations 
were increasingly presented in English, and I pub-
lished many articles in Acta Neuropathologica, 
founded in 1961 by Franz Seitelberger, who was 
editor-in-chief until 1987. 
The focus of clinical work and research were 
brain tumors, which were discussed in weekly clini-
co-pathological conferences with the Department 
of Neurosurgery. Tumor cell imprints for rapid di-
agnosis were introduced, which were confirmed by 




Fig. 5. Brain Cutting with (left to right) Hans Lassmann, Gernot 
Wöber (neurosurgeon), KJ, and Georg Spiel (later pediatric 
neurologist) in the Neurological Institute, 1966. Note the nu-
merous fixed brains in the glass jars in the back. 
 
In 1970, invited by M. Mossakowski, head of the 
Polish Academy of Sciences, I lectured about vari-
ous neuropathological subjects in Warsaw, Poznao, 
and Kraków, and was impressed by the lifestyle of 
the political upper class. At the 6th International 
Congress of Neuropathology in Paris, where I spoke 
about delayed radiation lesions of the spinal cord, 
Elisabeth and I were overwhelmed by the charm of 
France's capital. In Verona, the neuropathology of 
the “apallic syndrome” after head trauma was pre-
sented. In the same year, Seitelberger and Igor 
Klatzo, from the NIH, Bethesda, USA, organized an 
international symposium on axons and axonal flow, 
where I discussed neuroaxonal dystrophy in hu-
mans. 
In October 1971 Herbert Budka joined us and 
became my assistant for more than three years. 
We shared routine diagnostic neuropathology. 
Herbert recently described the situation and fur-
ther fate of the NI, and became director of the Clin-
ical Institute of Neurology, the successor of the NI 
after its transfer to the Allgemeine Krankenhaus 
(see [5]). In 1972, I lectured in Baltimore, Kansas 
City (J.J. Kepes' invitation), and New York.  
Heinz Regele, later chief of pathology in Linz, 
and I observed peculiar things that were described 
later by others. This included, in patients with brain 
death, finding cerebellar material around the cervi-
cal and thoracic spinal cord, which dropped down 
as sequelae of cerebellar incarceration due to in-
creased intracerebral pressure, later reported as a 
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characteristic finding in brain death (vita reducta). 
With Lothar Kucsko, a highly experienced 
pathologist and heavy smoker, a postmortem 
transorbital puncture of the brain in a patient with 
clinically-suspected CJD was performed. Under the 
electron microscope, I saw ruptured cell mem-
branes, which I initially interpreted as postmortem 
artifact, but Peter Lampert from the AFIP published 
these findings as typical lesions in CJD [6] - so we 
were too late!  
In the course of routine examination of brain 
tumor biopsies, I detected a large B cell lymphoma 
in the parietal lobe of a famous conductor. Erwin 
Deutsch, chairman of the Department of Internal 
Medicine, did not believe in my diagnosis, since 
whole body examination did not show any malig-
nancy. So I sent slides to Harry Zimmerman, chair-
man of neuropathology at Montefiore Hospital in 
New York, one of the world’s best neuropa-
thologists and mentor to generations of neuropa-
thologists, who confirmed my diagnosis. This pa-
tient survived for more than 12 years. Autopsy 
revealed a generalized immunocytoma, but no 
tumor residual in the brain. Together with Harry 
and Seitelberger, in 1974, an international sympo-
sium on malignant lymphomas of the central nerv-
ous system (CNS) in Vienna was organized, where 
experts discussed the classification of primary lym-
phomas of the CNS.  
In 1972, traumatic vascular diseases of the 
spinal cord were reviewed for the Handbook of 
Clinical Neurology. With T. Radaszkiewicz, an excel-
lent expert in lymphomas who unfortunately died 
too soon, a large collection of primary and second-
ary lymphomas of the CNS was published. In 1973, 
Hanno Bernheimer, Oleh Hornykiewicz (who died 
May 26, 2020), Walther Birkmayer, Franz Seitel-
berger, and I published a highly-cited paper (cur-
rently 3,005 citations) about dopamine in the syn-
dromes of Parkinson and Huntington. It was one if 
the first studies that correlated the neuropatholog-
ical findings in the striatonigral system (semiquanti-
tative assessment of neuronal loss in substantia 
nigra) and the biochemical data (dopamine and its 
metabolites) in a large number of autopsy cases [7]. 
During my time at the NI and afterwards, I ex-
tended brain autopsy service to several institutions 
outside of Vienna, including the neurological hospi-
tal in Linz. Since I had no car, I traveled by train. 
Once, on the return trip to Vienna, while transport-
ing sacks with freshly-dissected brains soaked with 
formalin to be examined in the NI, an acute train 
stop resulted some brains falling out of the sacks. I 
was almost arrested as a suspected mass murderer 
but the awful smell of formalin explained the reali-
ty. 
Later career 
In 1973, I was offered the position of chairman 
of the Division of Neuropathology at the Institute 
of Pathology in Zürich, but as I was number two on 
the list, Reinhard Friede was instead appointed. In 
February 1974, I was offered the position of profes-
sor and chairman of the Department of Neuropa-
thology at the Medical University Düsseldorf, Ger-
many, which after 2 years of unsuccessful negotia-
tions and for family reasons, I had to decline. Wolf-
gang Wechsler, then at the Max Planck Institute at 
Cologne, got this position which he held until his 
retirement in 1998.  
In 1975, in collaboration with Andras Guseo, a 
young neurologist from Székesfehérvár, Hungary 
and guest in the NI, the patterns of inflammatory 
perivascular infiltrates and their impact on the type 
and prognosis of multiple sclerosis were published. 
This was the beginning of a fruitful cooperation 
with the group of Hans Lassmann, then chief of the 
Neuroimmunology Division of the Austrian Acade-
my of Sciences and later of the Department of Neu-
roimmunology at the Institute for Brain Research in 
Vienna. In the same year, together with Felicia 
Slowik, a young neurooncologist from Budapest 
and guest in the NI, a large collection of biopsy and 
autopsy-proven meningiomas was examined with 
impact on the histological specificities and prognos-
tic relevance of various subtypes. 
In between, I was offered the position of head 
of the division of Neuropathology at Miami School 
of Medicine, FL. On this occasion, Elisabeth and I 
toured through the USA and I lectured at various 
universities. We got a deep impression about the 
way of living in the USA, which differed considera-
bly from ours. A few months later I was offered the 
position of head of the Division of Neuropathology 
at Case Western Medical School of Medicine, 
Cleveland, OH (successorship of R. Friede). Howev-
er, due to personal and family reasons, I declined 
all these positions.  
Since it was impossible to get an independent 
position in Vienna,, I finally decided to accept the 
position as Head of the Department of Neurology 
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at Lainz Hospital, one of the oldest municipal and 
teaching hospitals in Vienna. It was built between 
1908 and 1913 together with a large geriatric cen-
tre on the occasion of the 60th anniversary of Em-
peror Franz Josef's regency and was equipped with 
all facilities of modern medicine. During Julius Tan-
dler's time, a famous anatomist and counselor of 
health of the City of Vienna, Lainz Hospital became 
“a second university.” In 2006 it was fused with the 
nearby Neurological Hospital Rosenhügel as a neu-
rological center and is currently named Clinic Hietz-
ing. 
On October 12, 1976, I was appointed chief of 
the department of Neurology and became director 
of the Ludwig Boltzmann Institute of Clinical Neu-
robiology in January 1977, as successor of Walter 
Birkmayer, one of the “fathers” of research in PD. 
The Ludwig Boltzmann Society, named after the 
Austrian physicist Ludwig Boltzmann, was founded 
1960 as an Austrian network of specialized research 
institutes in the fields of medicine, humanities, and 
social sciences, all of which were sponsored by the 
City of Vienna and the Austrian government. In 
2002, the society was reorganized and the number 
of institutes greatly reduced. 
So, one career ended and a new area of neu-
roscience began, although many within the Vienna 
neurological community reacted with skepticism 
whether a neuropathologist would be able to man-
age a new clinical department. And, indeed, the 
beginning was difficult. The department had 75 
beds, part of them still occupied by geriatric pa-
tients, a waterbed ward, two trained nurses, and 
some auxiliary personnel but only a minimum of 
technical equipment. I had to find coworkers, some 
of whom needed a training position, which was not 
easy to organize. In addition to the clinical depart-
ment, which occupied the ground floor of the build-
ing, the histological and neurochemical labs on the 
second floor had to be equipped and prepared for 
functioning.  
My first coworkers from the previous neuro-
geriatric department were M. Podiwinsky, an elder-
ly neuropsychiatrist, and Roda Weiss, a young Ar-
menian doctor born in Odessa and married to a 
Viennese lawyer. Soon afterwards, Herbert Flament 
and Hannes Schmidt, two young neurologists in 
training from the nearby Rosenhügel hospital, and 
two specialists, Peter Kothbauer, nephew of the 
former Minister of Health, Ingrid Leodolter, and 
Edith Sunder-Plassmann, wife of a neurosurgeon, 
completed my first crew. Kothbauer later had to 
leave the department. Within a few years, I finally 
gathered a crew of 12 neurologists, most of them 
becoming excellent clinicians. For the neuropatho-
logical lab, Mrs. Veronika Rappelsberger followed 
me from the NI. Without her help, I would never 
have been able to do my routine work and research 
in neuropathology. I had to perform brain autop-
sies and biopsies for the whole hospital and geriat-
ric center and biopsies for a large neurosurgical 
department. Since I received no funding from the 
city, I had to pay my lab assistant from my own 
pocket. The chief of the neurochemistry lab was 
Peter Riederer, an experienced neurochemist who 
had graduated from the Technical University Vien-
na and, since 1971, had worked together with Wal-
ter Birkmayer in the Ludwig Boltzmann Institute 
(LBI) of Neurochemistry, the predecessor to the LBI 
of Clinical Neurobiology. Later, a number of stu-
dents and postdocs joined us. 
In addition to my new double functions, in 
1976, I was appointed editor-in-chief of Acta Neu-
ropathologica, after having acted as supplementary 
editor for several years. Between 1976 and 1981 I 
also edited the series “Current Topics in Neuropa-
thology” with selected papers from meetings of the 
Austrian Society of Neuropathology. In total, I edit-
ed or co-edited 10 books. 
With Peter Riederer, Wolf-Dieter Rausch, a 
dedicated post-doc who is currently Professor of 
Neurochemistry at the Veterinary University of 
Vienna, Paul Kruzik, and others, we examined the 
biochemistry of hepatic encephalopathy and the 
mode of action of L-deprenyl in the human CNS. 
Peter left Vienna in 1986 and became Professor of 
Neurochemistry and head of Clinical Neurochemis-
try at the Psychiatric Clinic of Würzburg Medical 
University until his retirement in 2008. We had a 
successful scientific cooperation and became close 
friends with him and his wife, Inge. Graduate engi-
neer Ildiko Wichart, a young neurochemist from 
Budapest, also joined our group and worked with 
us for many years even after her retirement.  
In addition to clinical service, with 1,700 to 
2,000 in-patients and an outpatient service with 
more than 15,000 consultancies per year, our de-
partment had to perform the neurological and psy-
chiatric consultant service for the whole hospital 
complex. The clinical crew published about brain 
tumors, intramedullary metastases, and lympho-
mas; while the neurochemistry group wrote about 
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neurotransmitters in metabolic encephalopathies, 
hepatic coma, brain infarcts, and deprenyl in the 
human brain. In June 1976, I gave lectures about 
CNS involvement by malignant lympho-
mas/leukemias and radiation-induced lesions of the 
CNS in New York, Philadelphia, and Baltimore. In 
1977, I received the award of the Vienna University 
Foundation, and in 1979 the Award of the Medical 
Scientific Foundation of the City of Vienna. 
We organized the first neurooncology group in 
Vienna, in which the preoperative examinations 
were done by my department, neurosurgery by the 
Hospital Rudolfstiftung (head H. Brenner), biopsy 
diagnosis, combined radiation, and polychemo-
therapy according to the COMT scheme, and post-
operative care by our department. We introduced 
modern CSF cytology, and studied cytological 
changes of gliomas caused by chemotherapy. The 
clinical crew was organized in a way that everyone 
had their own specialty: clinical neurology (Edith 
Sunder-Plassmann, Herbert Flament, Roda Weiss, 
Andrea Vass, Maria Grisold, Dieter Volc); and neu-
rophysiology (Rembert Vollmer, Wolfgang Grisold). 
With Alexander Meng, son of a Chinese professor 
of pediatrics and a Viennese mother, and a special-
ist in acupuncture and Traditional Chinese Medi-
cine (TCM), a successful multidisciplinary pain clinic 
was organized.  
Later, we performed the first biomarker 
screenings (total tau and β-amyloid-42) in CSF for 
the early diagnosis of Alzheimer disease (AD). The 
department got the first transmission Zeiss EM 9 
microscope in a city hospital, transferred from the 
LBI of Hematology (chief Alois Stacher, both an 
experienced hematologist and dedicated politi-
cian). 
In 1978, our neurochemistry group studied 
the activity of tyrosine hydroxylase (TH), the key 
enzyme of the dopaminergic system in the brain 
and adrenal medulla. We found that the TH activity 
was not only reduced in the striatonigral system by 
up to 90% but also in the adrenal medulla by about 
74% [8], a fact that questioned later research about 
transplantation of adrenal glands in patients with 
PD and would go on to save billions of dollars. 
In the background of this research, a laborato-
ry for muscle diseases and electromyography was 
opened with Wolfgang Grisold, one of the best 
clinical neurologists and neurophsiologists. He later 
became chief of the Neurology Department of 
Franz Josef Hospital, the LBI for Neurooncology, 
and is currently secretary of the World Federation 
of Neurology. 
Between 1975 and 1980, I wrote the chapter 
of pathology of the nervous system for several edi-
tions of the working book of pathology, edited by 
J.H. Holzner, successor of M. Chiari as chief of pa-
thology of the Vienna Medical University. In 1978, 
reviews about vascular tumors and malformations 
were published, and lectures were given in New 
York, Bethesda, and Washington (International 
Congress of Neuropathology). Again in collabora-
tion with Peter Riederer, the first Austrian-German 
brain bank was organized and we collected a host 
of neurodegenerative diseases, AD, PD, and normal 
controls, all of which was later transferred to Pe-
ter's lab in Würzburg. In 1980, with Filippo Gullotta, 
first chairman of the Department of Neuropatholo-
gy at Münster Medical School, Germany, and 
Miroslaw Mossakowski from Warsaw, the First 
European Congress of Neuropathology in Vienna 
was organized, bringing together many neuropa-
thologists in our city.  
In the following years, many new associates 
joined our group. Christian Bancher was active in 
both clinical and neuropathological research, with a 
focus on neurodegenerative and senile brain dis-
eases, and Werner Paulus, a postdoc from Germa-
ny, worked on brain tumors, lymphomas, and iron 
and ferritin in PD brains. He later became chairman 
of the Department of Neuropathology at Münster 
Medical School and editor-in-chief of Acta Neuro-
pathologica until 2019, and is the current editor-in-
chief of Free Neuropathology since 2020. 
My working day was full and split. Often, in 
the mornings, I went to pick up fresh brains from 
the nearby mortuary and carried them over the 
yard to the laboratory to dissect them for the brain 
bank, with one half being deep frozen for neuro-
chemistry and the other fixed in formalin for histo-
logical examination. The first part of the day was 
dedicated to clinical work and, after the morning 
conference with my coworkers, I went on clinical 
rounds twice a week and every Saturday. In be-
tween, I saw patients in the outpatient department 
or had conferences with other clinicians or neuro-
scientists. Meals were eaten together with doctors 
and nurses in the kitchen of the ward. The after-
noons were dedicated to neuropathology, brain 
cutting, and sign out (about 700 brains per year), or 
research in the EM lab (Fig. 1b). In addition, I pre-
pared a catalogue of all in-patients and their diag-
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noses on cards intended to be computerized later, 
which unfortunately was not possible at that time. I 
routinely read the letters of dismission (discharge) 
of patients, since all of my associates had to pre-
pare these letters spontaneously – “trust is good 
but control is better.” This usually lasted until night. 
Besides the clinic and the institute, I ran a small 
private praxis once or twice a week, together with 
Elisabeth, who was an ideal and helpful companion, 
loved by most of our patients. In addition, I served 
as court-certified expert witness for insurance 
companies or courts. So, my clinical duties were as 
broad as my scientific interests, which suited me 
very well and was tolerated by Elisabeth with great 
patience. 
International activities: the roaring 
eigthies 
In 1980, I was invited to speak by Prof. 
Hoshino, chairman of the Department of Neurosur-
gery, Teikyo University, Tokyo, one of the founders 
of high dose irradiation of brain tumors. In addition 
to lecturing, I reclassified the tumor collection of 
this department. During my 3-week stay in Japan, I 
got deep insights into the Japanese lifestyle, cul-
ture, and cuisine, not only in big cities but also in 
the countryside. Also around this time, I presented 
holoprosencephaly and agenesis of the corpus cal-
losum at the meeting of the American Association 
of Neuropathology in Vancouver, Canada. 
In 1982, together with F. Seitelberger, and H. 
Lassmann, the 9th International Congress of Neu-
ropathology in Vienna was organized, one of the 
most important meetings of this specialty in Vienna 
that was visited by about 700 specialists from all 
over the world. At a meeting about advances in 
neurotraumatology in Milan, October 1982, I pre-
sented brain stem involvement in blunt head inju-
ries and Elisabeth and I were welcomed by our 
Italian colleagues and we thoroughly enjoyed their 
hospitality and the flair of the city.  
Again with Peter Riederer, metabolic brain 
diseases, Dopa and tryptamine binding, selegiline 
effects, and lisuride in the treatment of PD were 
studied, thus broadening my experience beyond 
neuropathology. At a 1984 symposium on Parkin-
sonism in Bermuda, I was impressed by this won-
derful island. Between clinical work, congresses, 
routine neuropathology, and publishing scientific 
papers, my editorial work for Acta Neuropathologi-
ca occupied much of my private time. Since we had 
no computers or internet and I often read articles 
and proofs during bathing in our home, the journal 
caused some tension in our private life. 
Many of the clinical and clinicopathological 
presentations were performed together with 
members of my team, in particular with Wolfgang 
Grisold, one of the best neurologists I ever met, 
Dieter Volc, later chief of the Parkinson service in a 
private clinic, and Mrs. Elisabeth Kienzl, student of 
the Technical University Vienna and one of my best 
assistants in the laboratory. With Andreas Rett, an 
experienced neuropediatrist, a large number of 
brain malformations were studied. Franz Seitel-
berger, Dawna Armstrong, an outstanding pediatric 
neuropathologist from Houston, Texas, and I were 
among the first to extensively study the morpholo-
gy and neurochemistry of Rett syndrome. In 1985, I 
attended workshops in Baltimore and Bethesda, 
and was regularly invited to the annual meeting of 
the British Neuropathological Society. In addition to 
neurodegenerative disorders, the morphology and 
biochemistry of schizophrenia was studied with my 
cousin Eberhart Gabriel, director of the Vienna 
Psychiatric Otto Wagner Hospital and renowned 
historian in psychiatry. 
In 1986, I edited the book “Therapy of Malig-
nant Brain Tumours” (Springer Verlag, Vienna), in 
which international experts reviewed pathology, 
imaging, neurosurgery, radiation, and chemothera-
py of brain neoplasms. Between 1986 and 1999, I 
published chapters about neurodegenerative dis-
eases, brain tumors, and spinal circulation disor-
ders in the book series “Neurology in Clinic and 
Practice” and, in 1987, about pallidal degeneration 
in the “Handbook of Neurology.” In September 
1986, Elisabeth and I visited Stockholm for the 10th 
International Congress of Neuropathology, where I 
presented Rett syndrome and changes of subcorti-
cal nuclei in AD and PD. We were overwhelmed by 
this charming city and the hospitality of its citizens. 
In September 1986 I attended the workshop “Histo-
logical Classification of Tumors of the Nervous Sys-
tem” in Houston, Texas, which initiated a new clas-
sification of brain neoplasms (Fig. 6). In May 1988, I 
participated in the preparation of the 11th Interna-
tional Congress of Neuropathology 1990 in Kyoto 
and gave lectures in Tokyo, Sendai, and Niigata, 
where Elisabeth and I were hosted by Professor 
Iikuta, head of the Institute of Brain Research in 
Niigata and his wonderful wife, who spoke perfect 
English. Here, we saw the other side of the Japa-
nese island (Figs. 7 and 8).  
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Fig. 6. Brain Tumor meeting in Houston, Texas, 1988, with (left 
to right) Lucien Rubinstein, KJ, Lucy Rosko and Paul Kleihues. 
 
In March 1989, we had a wonderful Austrian 
Neuroscience Winter Meeting at Kitzbühel, and in 
April 1989 I discussed Lewy bodies at a Parkinson 
symposium in Chicago. The pathology of Parkinson 
syndrome was published in the Handbook of Exper-
imental Pharmacology, edited by Donald Calne, a 
pioneer of PD research. Between 1989 and 1991, 
Felicia Slowik, a highly experienced neurooncologist 
in Budapest worked with me on hemangiopericy-
tomas, the ultrastructure of malignant lymphomas, 
and cerebral sarcomas. With Werner Paulus, the 
neuropathological basis of different clinical sub-
groups of PD and their clinical relevance were stud-
ied. In 1991, I received the City of Vienna Prize for 
Medical Sciences. The next year, together with E. 
Kienzl and Emin Sofic, now professor of pharma-
cology, Faculty of Sciences, University of Sarajevo, 
selective increase of iron in the SN of PD and 
changes in the iron-melanin complex in the SN of 
PD brains with X-ray microanalysis were studied 
and presented at the Meeting of the Canadian As-
sociation of Neuropathology, September 1992 in 
Toronto, Canada. 
 
Fig. 7. Visit to Yashiko Shrine Hiigata, May 1988 with Prof. 
Kreutzberg and Prof. Ikuta. 
 
Fig. 8. Neuropathology and hospitality in Niigate, 1988. 
 
More work, more congresses 
In April 1990, I participated in The WHO Meet-
ing on Histological Classification of Tumors of the 
CNS, organized by my friend Paul Kleihues, chair-
man of neuropathology in Zürich and later director 
of the WHO International Agency for Research on 
Cancer in Lyon, France. Werner Paulus and I, to-
gether with 25 other distinguished brain tumor 
experts, participated in the meeting of the Blue 
Book’s Classification of Brain Tumours. The 2nd 
edition followed in 1993, the 3rd edition in 1997, 
and another in 2000, following a meeting in Lyon in 
1997, where I also participated. In its update, reti-
tled “Pathology and Genetics of Tumours of the 
Nervous System,” edited by P. Kleihues and W. 
Cavanee, with Werner Paulus, malignant lympho-
mas, histiocytic tumors, and melanotic lesions were 
reviewed. In August 1990, I presented primary cer-
ebral lymphomas at the International Cancer Con-
gress in Hamburg, and in September 1990, Elisa-
beth and I visited the 12th International Congress 
of Neuropathology in Kyoto, where we were hosted 
by Prof. Yonezawa, who is not only an excellent 
neuropathologist but also a gourmet and friend of 
the good life. Further highlights were the 5th World 
Congress of Biological Psychiatry in Florence in June 
1991, where I presented pathomorphological as-
pects of schizophrenia, and the 10th International 
Symposium of Parkinson's Disease in Tokyo in Oc-
tober 1991. At the Paneuropean Congress of Neu-
rology in Vienna, December 1991, the results of the 
Vienna Longitudinal Study of Dementia were pre-
sented, which showed correlations between cogni-
tive impairment and quantitative Alzheimer pa-
thology. 
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With Christian Bancher, the neuropathology of 
progressive supranuclear palsy (PSP) was reviewed 
in a book edited by Irene Litvan and Yves Agid. At 
this time, the clinical department was fully devel-
oped and successful, including a new laboratory for 
ultrasound examination of the cerebral vascula-
ture. Upon the 80th anniversary of Lainz Hospital, a 
Festschrift was published in 1993 that documented 
the progress of our department. In April 1993, the 
neuropathology and classification of PSP was dis-
cussed in Bethesda, MD, and I received the Eloise 
Troxel Memorial Grant of the Society for Progres-
sive Supranuclear Palsy, Baltimore, MD. 
At meetings in Tokyo in April 1994, I lectured 
on new developments in AD and the pathogenesis 
of PD. A further highlight was the 12th Internation-
al Congress of Neuropathology in Toronto in Sep-
tember 1994, where our group presented new data 
about cell death detected by DNA fragmentation 
and phospholipids in the Alzheimer brain. In 1994, 
together in a working group of Hans Lassmann, 
pathogenetic problems of multiple sclerosis were 
studied. That same year, with Werner Paulus, ad-
vances in the pathology of primary CNS lymphomas 
was also studied. A number of neurodegenerative 
disorders, like PSP, multiple system atrophy (MSA), 
and corticobasal degeneration (CBD) were studied 
in cooperation with an international group headed 
by Irene Litvan, now at University of California, San 
Diego, USA.  
In 1995, Christian Bancher and I described the 
neurofibrillary predominant form of senile demen-
tia, a rare subtype with low APOE ε4 genotype, 
which recently was renamed primary age-related 
tauopathy (PART) [9]. In 1995, the pathology of 
AIDS encephalopathy and, together with Herbert's 
group, the neuropathology and diagnostic criteria 
of CJD and other spongiform prion diseases were 
studied. In October 1995, I attended the Workshop 
on Dementia with Lewy bodies (DLB) in Newcas-
tle/Tyne, a dementing disorder hardly known at 
that time, and the guidelines for its diagnosis were 
published in the journal “Neurology” in 1996. 
Organizations and committees 
Through the years, I was elected to various na-
tional and international scientific organizations and 
committees. I served as vice president of the Inter-
national Society of Neuropathology between 1981 
and 1984; was chairman of the EU working group 
from 1996 to 1999; secretary of the European Soci-
ety of Psychopharmacology from 1994 to 2000; 
member of the FSN study group of neuropathology 
from 1987 to 2000; vice president of the Austrian 
Alzheimer Society from 1997 to 2002; president of 
the Viennese Association of Psychiatry and Neurol-
ogy in 1986/87; and president of the Austrian Soci-
ety of Neurology and Psychiatry from 1990-1992. 
From 1994 to 2000, I was a member of a commit-
tee reporting on neuroscience in Austria, on behalf 
of the Austrian Ministry of Sciences. Based on these 
data, a national program for neuroscientific re-
search for Austria was prepared in 1966, coordi-
nated by the LBI of Clinical Neurobiology as a basis 
for Austria's entry into the European Union. 
With increasing age, I became member and 
honorary member of national and international 
scientific societies, including the American, British, 
German, Hungarian, and Austrian Societies of Neu-
ropathology, the German Societies of Neurology 
and Pathology, the Austrian Neuroscience Associa-
tion, honorary member of the Austrian and German 
Parkinson Societies, the Scientific Commission of 
the German Hirnliga, among many others. During 
these years, I reviewed articles for multiple nation-
al and international journals and became editor or 
member of the editorial board of many of them. 
The great adventure: first Austrian 
neurologist in central China 
In March 1996, a delegation from the Austrian 
Society of Neurology was invited by the Chinese 
Ministry of Health to visit medical institutions and 
hospitals in China. This included 6 persons: Hans 
and Jutta Lassmann, Alexander Meng, Christian 
Bancher, Barbara Zeman, and myself. The tour was 
organized and guided by Mrs. Zhou Quin, program 
officer of the Department of International Coopera-
tion of the Chinese Ministry of Health (Fig. 9).  
We visited China from March 31 to April 14, 
1996. In Beijing, we were informed about the 
health organization in the People’s Republic of Chi-
na. During the weekend, we visited the Great Wall, 
the Ming graves, and the Imperial Palace. We then 
toured the neurological clinics of Beijing Hospital 
and of Capital Medical College, the two largest 
hospitals in the city, where Hans and I gave lectures 
about multiple sclerosis (MS) and PD. We flew to 
Chengdu, the capital of Sichuan, the largest prov-
ince of China, where we visited the Medical College 
for Traditional Chinese Medicine, which consisted 
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of traditional and Westernized parts, the first spe-




Fig. 9. First delegation of Austrian neurologists in central China, 
with Hans Lassmann, KJ, Zhou Quin, Jutta Lassmann, Barbara 
Zeman, Christian Bancher (left to right). 
 
We visited the largest herbal pharmacy of 
China and were invited to an herb dinner. On April 
6, a Sino-Austrian Symposium on Neurosciences 
was organized in which lectures about MS, PD, and 
other topics were presented. By invitation of the 
Minister of Health of Sichuan, we visited the Min 
river and the Buddhist grove sanctuaries in Bao-
dingshan and Beishan, which impressed us very 
much. After a short visit to Chongqing, a city with 
many respiratory diseases and lung cancers, we 
traveled by ship down the Jangtze River to Wuhan 
and visited the largest hospital of Hubei province, 
which had modern technical equipment and many 
German-trained professors. The journey on the 
Jangtse River, with the three gorges, was one of the 
most impressive adventures in our life.  
We experienced China's culture, landscape, 
and people, and passed the largest hydroelectric 
power station in China spanning the Yangtse River, 
which at that time was in construction and consid-
ered one of the most impressive technical projects. 
For reasons of time, a visit to Shanghai was not 
possible, and we returned to Vienna. In conclusion, 
all of us were deeply impressed by the landscape, 
the historical relics, culture, health institutions, life 
in the countryside, and, in particular, by the friend-
ly hospitality of our Chinese colleagues. 
Difficult times and new challenges 
In 1996, the Ludwig Boltzmann Society decid-
ed to dismiss Heinrich Gross, who had been in-
volved in the scandal about the euthanasia of hand-
icapped children in the Vienna psychiatric institu-
tion “Am Spiegelgrund” during Nazi times, and I 
was asked to take over his LBI for the research of 
malformations of the CNS, located in the Psychiat-
ric Hospital Baumgartner Höhe, which was now 
combined with the LBI of Clinical Neurobiology. 
While the formalin-fixed brains of these children 
were stored in the cellar of the Institute of Pathol-
ogy of this hospital, blocks of those brains had been 
secretly stored somewhere in the premises of these 
former LBIs and I had the difficult task to find these 
materials from the archives so that they may be 
buried in a special memorial, which took place in 
2002. This required much time to locate the specif-
ic material, to which I never had access before, 
while other specimens had been stored in the ar-
chives of the NI (see [5]). This affair was discussed 
in the popular media and had unforeseen political 
consequences, which hurt me, but I will not go into 
details.  
In 1996, together with Norbert Rösler, a post-
doc from Germany, the validity of CSF biomarkers 
(total tau and Amyloid-β-42) in the diagnosis of AD 
was studied. Christian Bancher and I visited an Alz-
heimer Congress in Osaka, Japan, and reported 
about the structural basis of dementia in AD and 
PD. The next year was of great importance for the 
department and myself, since I had reached the 
age of retirement from active service. However, my 
contract was prolonged for an extra year, during 
which we opened a stroke unit with 4 beds for sur-
veillance and intensive treatment of patients with 
acute stroke. Furthermore, Christian Bancher got 
the lectureship (Dozentur) in neurology and neuro-
pathology. In the years before, two other associ-
ates, Rembert Vollmer (neurology and neurophysi-
ology) and Wolfgang Grisold (neurology) had got 
their Dozentur.  
On September 30, 1997, I retired from my po-
sition as director of the department of Neurology 
at Lainz Hospital, but remained chief the LBI of 
Clinical Neurobiology, which was transferred to a 
building in the Psychiatrical Otto Wagner Hospital. 
Together with my lab assistant, Mrs. Rappels-
berger, I continued neuropathological routine work 
examining brains from a large psychiatric and geri-
atric hospital. Unfortunately, the archives of all the 
in-patients during the last 22 years, including the 
neuropathological protocols and brain material, 
was not available any more.  
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My successor was Dozent Manfred Schmid-
bauer, an excellent neurologist interested in neu-
ropathology, book author, and painter. After the 
fusion of Lainz Hospital with the nearby Neurologi-
cal Hospital Rosenhügel, Schmidbauer had to suc-
ceed the retired Gernot Schnabert as chief of both 
neurological departments. In addition, he contin-
ued routine neuropathology with focus on periph-
eral nerve biopsies. He retired in 2016 and became 
Professor of Neurodegenerative Diseases at the 
Sigmund Freud Private University in Vienna. He was 
succeeded by Christoph Baumgartner, a highly-
qualified epileptologist. However, this marked the 
end of neuropathology, which I had initiated and 
continued for 22 years. But I overcame this blow 
and continued scientific work. In addition to a small 
private praxis, I worked as a court-certified expert 
and still write second opinion expertises about 
difficult neurological problems. 
In October 1998, I presented data about 
movement disorders, malignant lymphomas, Lewy 
body disease, and tangle dementia in New York, 
Washington, Bethesda, and Montreal. At the 6th 
Conference on AD and related disorders, in Am-
sterdam in July 1998, I described vascular dementia 
and its relation with AD and received the Alzheimer 
Obelisk (Fig. 10).  
In 1999 and 2000, the foci of my interests 
were PD and related disorders, in particular MSA, 
as well as mechanisms of neuronal cell death, in-
cluding apoptosis. With Hallinah Baran, an experi-
enced neurochemist, later at the Veterinarian Uni-
versity Vienna, we studied kynurenine metabolism 
in AD, and with Christine Stadelmann, then assis-
tant in Lassmann's institute and now director of the 
Institute of Neuropathology, University Göttingen, 
we studied cell death mechanisms in neurodegen-
erative diseases.  
At a traditional medicine symposium in Vien-
na, I discussed the basis and impact of acupuncture 
in neurology. The same year, I was invited as guest 
professor of neuropathology at the Medical Univer-
sity Innsbruck, where I gave block lectures and 
seminars for students and colleagues. Since the 
Innsbruck University had no neuropathology at that 
time, I examined a number of autopsy cases of rare 
movement disorders, such as MSA and PSP. The 
symposium was hosted by Prof. Werner Poewe, 
chairman of Neurology, and Gregor Wenning, later 
chief of the Division of Clinical Neurobiology, with 
whom a long-lasting and fruitful cooperation and 
deep friendship began. 
 In 2000, I received the Burda Award of the 
Austrian Parkinson Society. In the same year, I was 
invited as guest professor at the Medical University 
of Graz, where I lectured about many subjects of 
clinical and theoretical neuropathology in the Clinic 
of Neurology under chairmen Erwin Ott and later 
Hans-Peter Hartung, now chairman of neurology in 
Düsseldorf, Germany. It was a wonderful time in 
the beautiful city of Graz and its surroundings, 
which I enjoyed very much. It was a leisure living 
compared to Vienna. 
In 2000, we described cell death mechanisms 
in PD and, in 2001, AIDS-related pathologies before 
and after antiretroviral therapy. Since 2002, I 
helped the Pathological Bacteriological Institute of 
the Otto Wagner Hospital in the diagnostic workup 
of postmortem brains, mainly from elderly de-
mented and non-demented individuals. I per-
formed brain cuttings once a week, and instructed 
colleagues how to dissect brains, which were exam-
ined in the LBI. My trainee and friend Johannes 
Attems, then assistant at the local Institute of Pa-
thology, examined the cases and we discussed 
them together between 2000 and 2008, thus giving 
him an excellent basis for his future career and a 
fruitful cooperation resulting in a number of shared 
publications. Since 2009, Johannes is Professor of 
Neuropathology and head of the brain bank at 
Newcastle University in England and, since recent-
ly, editor-in-chief of Acta neuropathological as suc-
cessor of Werner Paulus.  
In 2002, I received the prestigious award for 
Meritorious Contribution to Neuropathology by the 
American Association of Neuropathology, together 
with S. Horoupian, Professor Emeritus at Stanford 
University in the USA and Fusahiro IIkuta, director 
of the Brain research center at Niigata University, 
Japan. The laudation of my award was written by 
Robert D. Terry, one of the most important neuro-
pathologists of the 20th century and co-founder of 
US Alzheimer research (Addendum). We met on 
several occasions, including a visit to his home in 
California approximately one year before his death 
in May 2017. 
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Fig. 10. Presentation of the Alzheimer Obelisk with Dick Swab (left) and Henry Wisniewski (center) at the 6th Internat. Conference on 
AD, Amsterdam, July 1998. 
 
End of an institution and a new begin-
ning 
In 2002, the LBI of Clinical Neurobiology was 
closed despite it being one of the most active scien-
tific institutions outside the university with more 
than 1,400 publications until 2000. Since that year, 
we received no budget and I had to find other 
sponsors. The equipment was transferred to the 
new Institute of Clinical Neurobiology, which was 
run by the Society for the Support of Research in 
Experimental Neurology in Vienna, sponsored by 
donations and previous clinical trials. Since 1999, 
my assistant has been Dr. Erich Mitter-Ferstl, PhD, 
who studied at the Zurich Technical University and 
is an excellent computer specialist, without whom I 
hardly would have succeeded in this latest chapter 
of my career.  
Time went on with both continuing examina-
tion of brain material at the Wagner-Jauregg Hospi-
tal, evaluating old material, and continuing re-
search. In 2003, I wrote a chapter about the neuro-
pathology of PD in the book “Neurodegeneration” 
(ISN Neuropath Press, Basel) edited by the Interna-
tional Society of Neuropathology and again for the 
2nd edition, edited by D.W. Dickson and R.O. 
Weller in 2011. In 2007, a review of Lewy body 
disorders appeared in Abel Lajtha's book “Degen-
erative Diseases of the Nervous System” (Springer, 
Vienna) and since 2011, I continue to write the 
chapter on neuropathology of movement disorders 
in Youman’s Neurological Surgery (Elsevier Saun-
ders, Philadelphia, editor W.R. Winn), 6th edition, 
of which the 8th edition is currently in press. In 
2014, I contributed the chapters on neuropatholo-
gy and pathogenesis for the book “Multiple System 
Atrophy” (Springer, Wien) edited by G. Wenning 
and A.Fanciulli. Lastly, with Johannes Attems, the 
chapter on neuropathology for the “Textbook of 
Old Age Psychiatry,” (Oxford Univ. Press, Oxford, 
UK) the 2nd edition of which is now in press. 
We had a co-operation with the Vienna Trans-
danube Aging (VITA) study, a long-term inter-
institutional clinical, neuropsychological, genetic, 
neuroimaging, and neuropathological assessment 
of a large group of individuals aged 75 years in the 
eastern part of Vienna, which was performed by 
the LBI of Aging under the direction of Hans Tragl. 
For this group, with Ildiko Wichart, who worked at 
the University of Veterinary Medicine, Vienna, Aβ-
42 protein in plasma was studied and correlated as 
valid marker with many clinical and neuropsycho-
logical data, which resulted in a large number of 
publications and congress reports between 2005 
and 2010. Unfortunately, the VITA study ended for 
financial reasons, although it had been the first 
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population-based long-term study about risks and 
development of cognitive changes in the oldest of 
old people. 
In 2003, at the 3rd German Parkinson Con-
gress in Dresden, Heiko Braak, an outstanding neu-
roscientist, who, among others, introduced the 
staging of PD and AD pathologies, and I received 
the Lundbeck Award for Parkinson Research (Fig. 
11). In the same year, I received the Karl Maria 
Jakob Medal of the German Association of Neuro-
pathology in Hamburg. The co-operation with Jo-
hannes Attems studying olfactory involvement and 
multimorbidity of the aging brain and with Gregor 
Wenning’s team on Lewy body pathology was suc-
cessfully continued. Furthermore, with Mrs. E. 
Kienzl and a research group of the Neurological 
Clinic of the Technical University of Dresden (chief 
Heinz Reichmann), the Alzheimer Associated 
(ALZAS) gene was studied as a possible marker for 
AD. In 2005, I received the István Környey 
Tarscosag award on the occasion of the 100th 
birthday celebration of this eminent Hungarian 
neurologist, for whom I had the honor to present 
the laudation. In the same year, I contributed the 
chapter on synucleinopathies for the Polish Mossa-
kowski Memorial Book of Neuropathology 
(Wydawnictwo Czelej Sp. z o.o., Lublin, edited by 
P.D. Liberski and W. Papierz). Since 2006, I lecture 
on the neuropathology of stroke and vascular de-
mentia at the Danube University in Krems.  
The year 2006 was particularly busy. On the 
occasion of the 100th anniversary of Aloys Alzhei-
mer's description of the disease, several books 
appeared. In one edited by George Perry, the clini-
copathological results of a large series of demented 
elderly person were presented, and I published a 
book about the hallmarks of 100 years of scientific 
research on AD presenting the most important 
publications between 1938 and 1999 in German 
(translated by myself). In a book edited by H. Her-
holtz et al., I reviewed the early diagnosis of de-
mentias from the neuropathological point of view 
based on 1,500 consecutive autopsy cases in com-
parison to the clinical diagnoses, where I empha-
sized the impact of multi-morbidity.  
In October 2007, I lectured about Parkinson 
dementia in South Korea, vascular dementia in 
Budapest, and biological AD markers in Wroclaw, 
Poland. In 2008, together with Lassmann's group, 
the relations between MS and AD from the neuro-
immunological point of view were examined, and, 
at a Parkinson symposium in Tokyo, the formation 
and role of Lewy bodies were presented.  
Between 2005 and 2008, the Kurt Jellinger 
Prize for outstanding scientific writing in neuropa-
thology was sponsored by Acta Neuropathologica, 
for which I had served as executive editor for 29 
years. The last recipient was Goran Simic (2008) 
from the Brain Research Institute in Zagreb, who 
had been guest scientist in my LBI a few years be-
fore. In 2008, I found myself among the 20 highly-
cited scientists in Austria in the ISI Webb of 
Knowledge. Since Johannes Attems went to New-
castle uponTyne in Great Britain, I stopped lab 
work and concentrated on specific neuroscience 
problems, reviewing manuscripts, and writing invit-
ed review papers.  
 
 
Fig. 11. With Heiko Braak receiving the Lundbeck Award for 
Parkinson Research at the German Parkinson Congress 2003 in 
Dresden. 
 
 In 2011, I received the G. Cotzias Award of 
the Movement Study Group of the Spanish Society 
of Neuropathology in Barcelona. In honor of my 
80th birthday, four of my former scholars and now 
renowned neuroscientists, Hans Lassmann, Chris-
tian Bancher, Johannes Attems and Werner Paulus, 
dedicated a “Festschrift” of Acta Neuropathologica 
[10], for which I am very grateful to them. On the 
same occasion, my friends and former associates 
organized a festivity, which all of us enjoyed very 
much.  
Together with Johannes Attems and A. Thom-
as, the correlations between cortical and subcorti-
cal tau pathologies and their relations with Braak 
tau stages were reviewed, in addition to the patho-
logical correlates of behavioral disorders in demen-
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tias with M.F. Casanova and S.E. Starkstein, and the 
problem of vascular depression with an interna-
tional group. The role of α-synuclein in PD was pre-
sented in the book “Emerging Drugs and Targets for 
Parkinson's Disease,” (The Royal Society of Chemis-
try, Cambridge, UK) edited by A. Martinez and C. Gil 
in 2013. 
Invited in February 2013 by G. Logroscino, an 
US-trained Italian neurologist and neuroepidemiol-
ogist, I gave the Lectio Magistralis about the role of 
neuropathology in neurodegenerative diseases at 
the University of Bari, Italy. In June 2013, I dis-
cussed the role of α-synuclein as the gateway to 
neurodegeneration and demonstrated brain cutting 
to the members of the Division of Clinical Neurobi-
ology (head Gregor Wenning), with whom we cele-
brated our cooperation since 1993, which still per-
sists.  
In March 2014, Elisabeth and I were invited to 
a series of lectures at the Department of Neurology 
at Seoul National University, where we were host-
ed by Prof. Beomseok Jeon, a wonderful neurosci-
entist, who had overcome serious injuries in an 
alpine accident with utmost energy. We were 
overwhelmed by the megacity of Seoul that had 
been completely destroyed during the Civil War, 
and were deeply impressed by the lifestyle and 
culture of the Korean people. We never had expe-
rienced such a warm-hearted hospitality before. 
After this tour, I was invited for the position of Pro-
fessor of Neuropathology at Seoul, but I had to 
decline for age reasons.  
I like small and intimate meetings, such as 
those by the Society for Amelioration of the Quality 
of Life, organized by Stavros Baloyannis, chairman 
of Neurology at Thessaloniki Medical University, 
and sponsored by the Orthodox Church. These 
meetings occurred in Marseille 2008, Thessaloniki 
2009, Delphi 2010, and Catania, Sicily, in 2009, 
where Franz, Mrs. Gerstenbrand and I climbed the 
Aetna mountain. Other favorite meetings were the 
“Neurology Spring” in the Austrian Waldviertel, 
organized by Christian Bancher, now chief of Neu-
rology at Horn, and the World Congresses on Con-
troversies in Neurology (CONy), organized by Amos 
Korczyn, Professor emeritus in Tel Aviv, where 
problems in neurology are discussed by interna-
tional experts. 
In May 2015, I presented the pathogenesis of 
MSA at the α-synuclein symposium in Innsbruck 
then once more at the Congress on Vascular De-
mentia in Ljubljana in October 2015. Postmortem 
assessment in vascular dementia, a consensus re-
port on vascular depression, and the relations of 
diabetes mellitus and dementia were published in 
collaboration with international experts. Together 
with Amos Korczyn, an opinion paper discussing 
whether dementia with Lewy bodies and Parkinson 




Fig. 12. Workshop on neuropathological diagnosis of AD at the AD/PD Confernece in Lisbon, March 2019, with Johannes Attems, Irina 
Alafuzoff, KJ, Melissa Murray, Dieter Thal (left to right). 
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Together with Johannes Attems, Dietmar Thal, 
and Irina Alafuzoff, I helped lead a workshop on 
neuropathological diagnosis of AD, which was or-
ganized by Johannes at the AAIC Congresses in 
Copenhagen 2012, Washington 2015, and London 
2017; and again at the AD/PD congress in Nice 
2015 and Vienna 2017; and finally, with Johannes 
Attems, Irina Alafuzoff, Dietmar Thal, and Melissa 
Murray at the AD/PD conference in Lisbon, March 
2019 (Fig. 12). My last congressional activities were 
the annual meeting of the Austrian Parkinson Soci-
ety in Vienna in speaking about Parkinson dementia 
and dementia with Lewy bodies, and a biological 
definition of the Alzheimer spectrum at a course 
about CNS proteinopathies in Milan, Italy in No-
vember 29, 2019. 
Now, at the age of 89, I still find it impossible 
to abandon my interest in neuropathology, and I 
try to continue scientific work as long and as well as 
I can. In the last year, I discussed whether Braak 
staging is valid for all types of PD, and, together 
with Gregor Wenning's group, protective therapies 
in MSA. After two extensive reviews about the neu-
ropathology and pathogenesis of extrapyramidal 
disorders, the neuropathology of cognitive impair-
ment in MSA and an update of MSA were pub-
lished. Two reviews of the pathobiological defini-
tion of Alzheimer continuum, including the neuro-
pathology of its pathobiological subtypes, are in 
press. 
Life beyond neurology/  
neuropathology 
Although I “was married to neuropathology,” 
together with Elisabeth, we had an intensive and 
happy private life, as busy as it has been. Before 
our wedding in August 1960, we rented a flat that 
took years to get completely refurnished. Elisabeth 
was a student, and I a poorly-paid university assis-
tant. In summer 1958, she was an au pair with a 
family in London, while I was paramedic in a sum-
mer camp for students in Italy. In 1959, we spent a 
splendid summer vacation on the island of Maly 
Losinj at the Croatian coast, where I had helped to 
reestablish the school. In 1960, we spent our hon-
eymoon in Lignano and Venice, and the next year 
we went to the Greek island of Mykonos, where we 
were among the very few tourists on this beautiful 
island, which later became a hotspot of elegant 
tourism. Elisabeth finished her studies in English 
with a thesis about the medieval Towneley plays, 
which I typed. Later, she became administrator in 
the Institute of Immunology of Vienna Medical 
Faculty, run by my friend Prof. Martha Eibl. After-
wards, Elisabeth joined me in literature research 
and as an assistant in my private medical practice, 
where she was loved by all my patients.  
In springtime, we traveled to southern coun-
tries, in particular Toscana, Umbria, the Marches, 
Romne, Gubbio, Urbino, Arezzo, Parma, Sicily, Cor-
sica, Burgundy, Bretagne, and many other interest-
ing regions, where we enjoyed the lifestyles, local 
gastronomy, cultures, and traditions. In summer we 
had regular vacations on many Greek islands, but 
also in Sicily, Mallorca, and Sardinia. In summer 
1986, we spent our vacation in a beach house of 
my friend Nenad Grčevid, an excellent Croatian 
neuropathologist, in Umag, a small town on the 
Istrian peninsula, when the “Prague Spring” was 
suppressed by the Soviet army. In 1996, after a 
peaceful stay at Syros, we escaped from the island, 
afraid of a possible war between Greece and Tur-
key, and had to wait in Athens for a flight home. 
Later, many summers were spent on the beautiful 
island of Chios, which is next to the Turkish border, 
in a small hotel run by a friendly Greek family, but 
during the last years we could not go there because 
of the refugee crisis and lack of direct flights.  
At Christmas time and New Year, we used to 
spend some weeks in Paris, which we loved for its 
culture and way of life. Unfortunately, during this 
past year we could not go to our beloved Hotel De 
La Bretonnerie in the old Marais district because of 
the yellow jacket riots and the novel coronavirus 
pandemic. 
During the rest of the year, we regularly at-
tend the Vienna Opera and concerts. For years, we 
have had subscriptions to the Vienna Philharmonic 
Orchestra and many other chamber music presen-
tations. In previous times, we regularly visited the 
Salzburg Festivals, where we met friends, many of 
them being members of the Vienna Philharmonic 
Orchestra. During leisure time, I regularly read his-
torical books and try to inform myself about Austri-
an and international history. We like to walk in the 
idyllic landscape and, in order to exercise our 
brains, Elisabeth and I take regular Italian lessons 
with a nice Italian interpreter.  
In 1969, my late father-in-law built a small 
house in Maiersdorf, a small village at the foot of 
the Hohe Wand, a mountain of 1,200 meters, about 
65 km south of Vienna, which we visited nearly 
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every weekend in summertime and around Christ-
mas. Since March 13, 2020, and with few interrup-
tions, we have lived in this house during the COVID-
19 lockdown, and it is here, in the tranquil land-
scape and beautiful springtime, that I wrote the 
major part of this report.  
Once the lockdown ends, we hope that “nor-
mal life” will resume, although this virus is still an 
enormous and expanding danger for the whole 
world. However, we don't agree with the slogan in 
a humorist Vienna journal in July 1918: “The Span-
ish Influenza finishes us all,” and, despite all warn-
ings, we are looking optimistically to the future. We 
just celebrated the 60th anniversary of our wed-
ding not on a Greek island but in our rural home. 
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